Project Grant 2228581

Award Date 1/15/23
Completion Date 12/31/24
Dollars Obligated $140K
Federal Grant Program
47.083
Assistance Type
Project Grant
Place of Performance
Ruston, LA 71272, USA
Similar Awards
The National Science Foundation (NSF) awarded a $206,875 Project Grant (CFDA 47.074 - Biological Sciences) to Louisiana Tech University to host the "Next Generation of Conversations" conference series. The goal is to foster global collaboration and knowledge exchange in computational, theoretical, and experimental biomolecular research, engaging scientists from Nobel Laureates to early career researchers. The conference will be held at Louisiana Tech University, strategically located...
This $546,600 Project Grant awarded by the National Science Foundation's (NSF) Integrative Activities program (CFDA 47.083) aims to engineer mesenchymal stem cell-derived exosomes (MSC-EXO) for targeted immunomodulation and enhanced bone repair. The University of Maryland Eastern Shore (UMES), a historically black, 1890 land-grant institution, is the primary awardee. The key objectives of this 3-year project are to: 1) generate engineered exosomes (TEX) for reprogramming macrophages, 2) modify...
The National Science Foundation awarded the University of Louisville a $358,793 project grant under the Biological Sciences program (CFDA 47.074) to develop a microfluidic platform for dielectric characterization of biological nanoparticles. A team of graduate, undergraduate, and high school students will design and build the system using microfabrication techniques, gaining entrepreneurial training through university programs. The specialized platform will enable fundamental insight into...
The National Science Foundation (NSF) Biological Sciences (CFDA 47.074) program awarded a $637,920 Project Grant to Louisiana State University (LSU) with a performance period from August 1, 2024 to July 31, 2029. The grant supports research to understand the structure, function, and signaling pathways of the integrin αvβ8 receptor protein, which plays a critical role in nerve cell development and attachment to the extracellular matrix. The project aims to determine how this integrin adopts an...
This National Science Foundation (NSF) grant award under the Mathematical and Physical Sciences (CFDA 47.049) Federal Grant Program provides $280,000.00 to Professor W. Andy Tao's research group at Purdue University. The goal of this 3-year project is to develop a new mass spectrometry-based strategy to analyze the RNA-binding proteins involved in cell-cell communication through extracellular vesicles (EVs). The research will introduce a chemical tagging approach to profile the landscape of EV...
This National Science Foundation (NSF) Project Grant under CFDA Number 47.041 - Engineering provides $360,000 in funding to Cornell University from July 1, 2023 to June 30, 2026 to develop a novel biosensing platform for the simultaneous detection and quantification of exosomes (small vesicles released from cells) and their molecular cargo. The key objectives are to: (1) develop methods to capture, quantify, and profile exosomes using a plasmonic biosensor; (2) develop techniques to lyse the...
This National Science Foundation (NSF) Project Grant under the Integrative Activities program (CFDA 47.083) provides $128,826 to Louisiana TECH University to acquire a Nanoparticle Tracking Analyzer (NTA) instrument. The NTA will enable real-time analysis of nanomaterials, benefiting research across disciplines including biomanufacturing, pharmaceutical development, and environmental protection. The instrument will support the work of 5 postdocs, 31 graduate students, and 60 undergraduates,...
This $337,863 Project Grant awarded by the National Science Foundation's (NSF) Division of Chemistry under the Mathematical and Physical Sciences program (CFDA 47.049) supports research by Professor Ken Marcus and his team at Clemson University to develop new methods for isolating and purifying diverse biological nanoparticles, including exosomes, lentiviruses, and adeno-associated viruses. The researchers aim to characterize and implement a unique fiber-based stationary phase,...
This National Science Foundation (NSF) Project Grant, awarded under the Biological Sciences program (CFDA 47.074), provides $154,000 in funding to Boston University from July 1, 2024 to June 30, 2027 to conduct research on protein aggregation and liquid-liquid phase separation (LLPS). The project, a collaborative effort between US and French researchers, aims to elucidate how protein-rich droplets can promote the pathological aggregation of proteins associated with neurodegenerative diseases,...
This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection to...

This $140,314 National Science Foundation project grant under the Integrative Activities program (CFDA 47.083) will fund research and training related to exosome proteomics analysis and biomarker discovery for cancer diagnostics. Louisiana Tech University will collaborate with the University of Houston to identify glioblastoma-specific protein biomarkers in exosomes purified from biofluids using disease-specific surface markers. The Principal Investigator and one graduate student will receive specialized training in mass spectrometry proteomics analysis at the University of Houston to profile exosomes derived from healthy and glioblastoma-infected astrocytes. They will also evaluate Louisiana Tech's ExoPrime immunocapture tool for purifying glioblastoma-derived exosomes expressing EPCAM, EGFRVIII, or HSP-27 markers to identify potential diagnostic biomarkers. Expertise gained from this fellowship will enhance proteomics education at Louisiana Tech. Results have potential to advance non-invasive early disease diagnostics through improved understanding of tumor-specific exosome proteome profiles.

Generated 1/6/24, 1:49 PM